192 related articles for article (PubMed ID: 12952762)
21. Phase I study of docetaxel administered by bi-weekly infusion to patients with metastatic breast cancer.
Shin E; Ishitobi M; Hiraoia M; Kazumasa F; Hideyuki M; Nishisho I; Toshiro S; Yasunori H; Tosimasa T
Anticancer Res; 2000; 20(6C):4721-6. PubMed ID: 11205207
[TBL] [Abstract][Full Text] [Related]
22. [Low-dose weekly administration of docetaxel for metastatic breast cancer].
Kimijima I; Watanabe T; Sagara H; Ohtake T; Tsuchiya A; Abe R
Gan To Kagaku Ryoho; 1999 Jun; 26(7):995-9. PubMed ID: 10396330
[No Abstract] [Full Text] [Related]
23. The development of docetaxel (Taxotere) in non-small cell lung cancer.
Kris MG; Miller VA; Ng KK; Grant SC
Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-1-S14-4. PubMed ID: 9335515
[No Abstract] [Full Text] [Related]
24. Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trial.
Hesketh PJ; Crowley JJ; Burris HA; Williamson SK; Balcerzak SP; Peereboom D; Goodwin JW; Gross HM; Moore DF; Livingston RB; Gandara DR
Cancer J Sci Am; 1999; 5(4):237-41. PubMed ID: 10439170
[TBL] [Abstract][Full Text] [Related]
25. Severe nail changes due to Docetaxel treatment.
Rafi L; Friedrich M; Tilgen W; Reichrath J
Eur J Dermatol; 2003; 13(6):610-1. PubMed ID: 14721789
[TBL] [Abstract][Full Text] [Related]
26. Phase II study of weekly albumin-bound paclitaxel for patients with metastatic breast cancer heavily pretreated with taxanes.
Blum JL; Savin MA; Edelman G; Pippen JE; Robert NJ; Geister BV; Kirby RL; Clawson A; O'Shaughnessy JA
Clin Breast Cancer; 2007 Dec; 7(11):850-6. PubMed ID: 18269774
[TBL] [Abstract][Full Text] [Related]
27. Nail toxicity related to weekly taxanes: an important issue requiring a change in common toxicity criteria grading?
Spazzapan S; Crivellari D; Lombardi D; Scuderi C; Magri MD; Veronesi A; Gatti A
J Clin Oncol; 2002 Nov; 20(21):4404-5; author reply 4405. PubMed ID: 12409345
[No Abstract] [Full Text] [Related]
28. Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma.
Koukourakis MI; Bahlitzanakis N; Froudarakis M; Giatromanolaki A; Georgoulias V; Koumiotaki S; Christodoulou M; Kyrias G; Skarlatos J; Kostantelos J; Beroukas K
Br J Cancer; 1999 Aug; 80(11):1792-6. PubMed ID: 10468298
[TBL] [Abstract][Full Text] [Related]
29. Docetaxel extravasation causing significant delayed tissue injury.
Raley J; Geisler JP; Buekers TE; Sorosky JI
Gynecol Oncol; 2000 Aug; 78(2):259-60. PubMed ID: 10926814
[TBL] [Abstract][Full Text] [Related]
30. Weekly docetaxel/paclitaxel in pretreated metastatic breast cancer.
Gennari A; Guarneri V; Landucci E; Orlandini C; Rondini M; Salvadori B; Ricci S; Conte PF
Clin Breast Cancer; 2002 Dec; 3(5):346-52. PubMed ID: 12533265
[TBL] [Abstract][Full Text] [Related]
31. Docetaxel-induced radiation recall dermatitis and successful rechallenge without recurrence.
Camidge DR; Kunkler IH
Clin Oncol (R Coll Radiol); 2000; 12(4):272-3. PubMed ID: 11005698
[No Abstract] [Full Text] [Related]
32. Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments.
Feldweg AM; Lee CW; Matulonis UA; Castells M
Gynecol Oncol; 2005 Mar; 96(3):824-9. PubMed ID: 15721432
[TBL] [Abstract][Full Text] [Related]
33. Blockage of the lacrimal drainage apparatus as a side effect of docetaxel therapy.
Esmaeli B; Hidaji L; Adinin RB; Faustina M; Coats C; Arbuckle R; Rivera E; Valero V; Tu SM; Ahmadi MA
Cancer; 2003 Aug; 98(3):504-7. PubMed ID: 12879466
[TBL] [Abstract][Full Text] [Related]
34. An interesting antitumor drug in the elderly patients over the age of 70: weekly docetaxel.
Frontini L
Tumori; 2002; 88(1 Suppl 1):S41-3. PubMed ID: 11989922
[No Abstract] [Full Text] [Related]
35. Drugs and nails.
Uyttendaele H; Geyer A; Scher RK
J Eur Acad Dermatol Venereol; 2004 Mar; 18(2):124-5. PubMed ID: 15009285
[No Abstract] [Full Text] [Related]
36. Isolated lung perfusion with Paclitaxel and docetaxel: comparison of the early effects on pulmonary physiology.
Tanju S; Akpolat B; Senturk E; Ziyade S; Toker A; Yilmazbayhan D; Aydiner A; Dilege S
Thorac Cardiovasc Surg; 2007 Apr; 55(3):177-9. PubMed ID: 17410504
[TBL] [Abstract][Full Text] [Related]
37. Hypertrophic osteoarthropathy associated with docetaxel treatment.
Tas F; Aydiner A; Tenekeci N; Karadeniz A; Sakar B; Topuz E
Clin Oncol (R Coll Radiol); 2001; 13(2):145-6. PubMed ID: 11373880
[No Abstract] [Full Text] [Related]
38. Onycholysis as a complication of systemic chemotherapy: report of five cases associated with prolonged weekly paclitaxel therapy and review of the literature.
Hussain S; Anderson DN; Salvatti ME; Adamson B; McManus M; Braverman AS
Cancer; 2000 May; 88(10):2367-71. PubMed ID: 10820360
[TBL] [Abstract][Full Text] [Related]
39. Drug interactions with the taxanes.
Baker SD
Pharmacotherapy; 1997; 17(5 Pt 2):126S-132S. PubMed ID: 9322879
[TBL] [Abstract][Full Text] [Related]
40. Onycholysis associated with paclitaxel.
Mackay-Wiggan J; Nair KG; Halasz CL
Cutis; 2003 Mar; 71(3):229-32. PubMed ID: 12661751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
